Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HHV8 anticorps (C-Term)

HHV8 Reactivité: Humain WB, EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN401445
  • Antigène Tous les produits HHV8
    HHV8 (Herpes Virus Type 8 (HHV8))
    Épitope
    C-Term
    Reactivité
    • 3
    • 2
    • 1
    Humain
    Hôte
    • 2
    • 2
    • 2
    Lapin
    Clonalité
    • 4
    • 2
    Polyclonal
    Conjugué
    • 6
    Cet anticorp HHV8 est non-conjugé
    Application
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Purification
    Affinity chromatography
    Immunogène
    Synthetic peptide corresponding to a region near the C-terminal of human KSHV ORF57 protein
    Isotype
    IgG
  • Indications d'application
    ELISA: 1/100,000 - 1/170,000. Western Blot: 1/5,000 - 1/8,000.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.55 mg/mL (by UV absorbance at 280 nm)
    Buffer
    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 containing 0.01 % (w/v) Sodium Azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    -20 °C
  • Antigène
    HHV8 (Herpes Virus Type 8 (HHV8))
    Autre désignation
    Herpes Virus Type 8 / HHV8 (HHV8 Produits)
    Classe de substances
    Virus
    Sujet
    ORF57 (also known as MTA), one of the earliest Kaposi's sarcoma-associated herpesvirus (KSHV) regulatory proteins to be expressed, is essential for virus lytic replication. A counterpart is present in every herpesvirus sequenced, indicating the importance of this signature viral protein, and those examined act post-transcriptionally, affecting RNA splicing and transport. KSHV ORF57 is capable of establishing both lytic and latent replication cycles. In KS, the virus localizes to tumor progenitor endothelial cells, most of which are latently infected. In cell culture, KSHV replication is generally studied using B-cell lines, such as BCBL-1, generated from primary effusion lymphoma material. Most BCBL-1 cells are latently infected, although there is some spontaneous virus reactivation. Addition of chemical inducers such as sodium n-butyrate, 12-O-tetradecanoylphorbol-13-acetate (TPA), and valproic acid (VA) to these cells efficiently induces the lytic cycle and produces virions. KSHV ORF57 protein predominantly localizes to the nucleus and can shuttle between the nucleus and cytoplasm. Most HSV-1 genes are unspliced, by contrast, ORF57 is spliced gene, the protein is 455 amino acids in length and 50 kDa in size.Synonyms: HHV-8, KHSV
Vous êtes ici:
Support technique